2315
HKSE:2315
Biocytogen Pharmaceuticals (Beijing) Co., Ltd.
- Stock
Last Close
6.37
30/08 07:58
Market Cap
3.05B
Beta: -
Volume Today
153K
Avg: 161.05K
PE Ratio
−7.72
PFCF: −5.73
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Mar '21 | Jun '21 | Sep '21 | Dec '21 | Mar '22 | Jun '22 | Sep '22 | Dec '22 | Mar '23 | Jun '23 | Sep '23 | Dec '23 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
net income | -124.64M - | -124.64M 0% | -148.15M 18.87% | -148.15M 0% | -136.19M 8.07% | -136.19M 0% | -164.78M 20.99% | -164.78M 0% | -94.90M 42.41% | -94.90M 0% | -96.57M 1.76% | -96.57M 0% | |
depreciation and amortization | 22.73M - | 22.73M 0% | 41.32M 81.82% | 41.32M 0% | 38.70M 6.34% | 38.70M 0% | 48.35M 24.93% | 48.35M 0% | 42.03M 13.07% | 42.03M 0% | 52.96M 26.00% | 52.96M 0% | |
deferred income tax | 6.90M - | -215.60M 3,222.99% | |||||||||||
stock based compensation | 6.32M - | 6.32M 0% | 7.55M 19.44% | 7.55M 0% | 9.06M 20.01% | 9.06M 0% | -1.41M 115.52% | -1.41M 0% | 6.20M 540.62% | 6.20M 0% | 9.29M 49.82% | 9.29M 0% | |
change in working capital | -22.98M - | -22.98M 0% | -5.50M - | -5.50M 0% | |||||||||
accounts receivables | -17.93M - | -17.93M 0% | -2.30M - | -2.30M 0% | |||||||||
inventory | -14.98M - | -14.98M 0% | -3.20M - | -3.20M 0% | |||||||||
accounts payables | -112.82M - | ||||||||||||
other working capital | 9.93M - | 9.93M 0% | 112.82M - | ||||||||||
other non cash items | 17.33M - | 17.33M 0% | 17.63M 1.77% | 17.63M 0% | 32.85M 86.30% | 32.85M 0% | 20.38M 37.96% | 242.88M 1,091.86% | 37.89M 84.40% | 37.89M 0% | 4.79M 87.37% | 4.79M 0% | |
net cash provided by operating activities | -78.26M - | -78.26M 0% | -104.63M 33.69% | -104.63M 0% | -55.58M 46.88% | -55.58M 0% | -96.05M 72.82% | -96.05M 0% | -8.78M 90.85% | -8.78M 0% | -29.54M 236.26% | -29.54M 0% | |
investments in property plant and equipment | -61.54M - | -61.54M 0% | -37.79M 38.60% | -37.79M 0% | -68.10M 80.20% | -68.10M 0% | -52.04M 23.59% | -52.04M 0% | -45.12M 13.29% | -45.12M 0% | 45.12M 200% | 45.12M 0% | |
acquisitions net | 2.32M - | 262.38K - | |||||||||||
purchases of investments | -10.89M - | ||||||||||||
sales maturities of investments | -6.90M - | ||||||||||||
other investing activites | -96.61M - | -96.61M 0% | 153.88M 259.28% | 153.88M 0% | 46.61M 69.71% | 46.61M 0% | -3.35M 107.18% | 12.13M 462.40% | 116K 99.04% | -146.38K 226.19% | -50.26M 34,231.88% | -50.26M 0% | |
net cash used for investing activites | -158.15M - | -158.15M 0% | 116.09M 173.40% | 116.09M 0% | -21.48M 118.51% | -21.48M 0% | -55.38M 157.79% | -55.38M 0% | -45.01M 18.74% | -45.01M 0% | -5.13M 88.59% | -5.13M 0% | |
debt repayment | -21.66M - | -19.32M - | -44.86M - | ||||||||||
common stock issued | 558.90M - | -2.91M - | |||||||||||
common stock repurchased | -9.49M - | -9.49M 0% | -4.33M 54.35% | -4.33M 0% | |||||||||
dividends paid | -112.04M - | -32.33M - | |||||||||||
other financing activites | 122.65M - | 122.65M 0% | -12.93M 110.54% | -12.93M 0% | 5.98M 146.24% | 5.98M 0% | 297.11M 4,868.44% | -130.43M 143.90% | 15.09M 111.57% | 95.19M 530.84% | -29.66M 131.16% | -29.66M 0% | |
net cash used provided by financing activities | 122.65M - | 122.65M 0% | -12.93M 110.54% | -12.93M 0% | 5.98M 146.24% | 5.98M 0% | 287.62M 4,709.70% | 287.62M 0% | 10.76M 96.26% | 10.76M 0% | -29.66M 375.81% | -29.66M 0% | |
effect of forex changes on cash | 1.43M - | 1.43M 0% | -1.62M 213.32% | -1.62M 0% | 3.78M 333.63% | 3.78M 0% | 3.35M 11.40% | 3.35M 0% | 4.97M 48.67% | 4.97M 0% | -3.24M 165.13% | -3.24M 0% | |
net change in cash | -112.34M - | -112.34M 0% | -3.09M 97.25% | -3.09M 0% | -67.31M 2,080.39% | -67.31M 0% | 139.53M 307.29% | 296.79M 112.71% | -38.06M 112.82% | -109.01M 186.40% | -67.58M 38.01% | -67.58M 0% | |
cash at beginning of period | 584.96M - | 472.62M 19.20% | 399.14M - | 331.83M 16.86% | 406.74M 22.58% | 703.53M - | |||||||
cash at end of period | -112.34M - | 472.62M 520.71% | 469.53M 0.65% | -3.09M 100.66% | -67.31M 2,080.39% | 331.83M 593.00% | 471.36M 42.05% | 703.53M 49.26% | -38.06M 105.41% | 594.52M 1,662.01% | -67.58M 111.37% | -67.58M 0% | |
operating cash flow | -78.26M - | -78.26M 0% | -104.63M 33.69% | -104.63M 0% | -55.58M 46.88% | -55.58M 0% | -96.05M 72.82% | -96.05M 0% | -8.78M 90.85% | -8.78M 0% | -29.54M 236.26% | -29.54M 0% | |
capital expenditure | -61.54M - | -61.54M 0% | -37.79M 38.60% | -37.79M 0% | -68.10M 80.20% | -68.10M 0% | -52.04M 23.59% | -52.04M 0% | -45.12M 13.29% | -45.12M 0% | 45.12M 200% | 45.12M 0% | |
free cash flow | -139.81M - | -139.81M 0% | -142.42M 1.87% | -142.42M 0% | -123.68M 13.16% | -123.68M 0% | -148.09M 19.74% | -148.09M 0% | -53.91M 63.60% | -53.91M 0% | 15.58M 128.91% | 15.58M 0% |
All numbers in HKD (except ratios and percentages)